Antifungal activity of dehydrocurvularin for Candida spp. through the inhibition of adhesion to human adenocarcinoma cells.


Journal

The Journal of antibiotics
ISSN: 1881-1469
Titre abrégé: J Antibiot (Tokyo)
Pays: England
ID NLM: 0151115

Informations de publication

Date de publication:
09 2022
Historique:
received: 28 03 2022
accepted: 01 07 2022
revised: 27 06 2022
pubmed: 22 7 2022
medline: 11 8 2022
entrez: 21 7 2022
Statut: ppublish

Résumé

Cell adhesion plays a crucial role in candidiasis through invasion of the human body and obtaining resistance to drugs by forming biofilms. Cell adhesion thus is a critical target for combating candidiasis by preventing the entry of fungal hyphae into the epithelium. We report here that dehydrocurvularin (1), isolated from the marine-derived fungus Curvularia aeria, exhibited anti-fungal activities for Candida albicans and Candida auris. This compound also prevented the adherence of C. albicans to human adenocarcinoma cells. Real-time RT-PCR analysis showed that exposure to 1 results in decreased expression of HWP1, EFG1, and ECE1, genes involved in Candida adhesion to epithelial cells and hyphal morphogenesis.

Identifiants

pubmed: 35859164
doi: 10.1038/s41429-022-00543-5
pii: 10.1038/s41429-022-00543-5
doi:

Substances chimiques

Antifungal Agents 0
Fungal Proteins 0
dehydrocurvularin 21178-57-4
Zearalenone 5W827M159J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

530-533

Subventions

Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP20K16029

Informations de copyright

© 2022. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

Références

Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17:255–67.
doi: 10.1128/CMR.17.2.255-267.2004
Agnew-Francis KA, Tang Y, Lin X, Low YS, Wun SJ, Kuo A, Elias SMASI, Lonhienne T, Condon ND, Pimentel BNAS, Vergani CE, Smith MT, Fraser JA, Williams CM, Guddat LW. Herbicides that target acetohydroxyacid synthase are potent inhibitors of the growth of drug-resistant Candida auris. ACS Infect Dis. 2020;6:2901–12.
doi: 10.1021/acsinfecdis.0c00229
Sionov RV, Feldman M, Smoum R, Mechoulam R, Steinberg D. Anandamide prevents the adhesion of filamentous Candida albicans to cervical epithelial cells. Sci Rep. 2020;10:13728.
doi: 10.1038/s41598-020-70650-6
kobayashi A, Hino T, Yata S, Itoh TJ, Sato H, Kawazu K. Unique spindle poisons, curvularin and its derivatives, isolated from Penicillium species. Agic Biol Chem. 1988;52:3119–23.
Xie LW, Ouyang YC, Zou K, Wang GH, Chen MJ, Sun HM, Dai SK, Li X. Isolation and difference in anti-Staphylococcus aureus bioactivity of curvularin derivates from fungus Eupenicillium sp. Appl Biochem Biotechnol. 2009;159:284–93.
doi: 10.1007/s12010-009-8591-2
CLSI: Reference method for broth dilution anti-fungal susceptibility testing of yeasts: approved standard-second edition (M27-A3) Wayne PA 2002.
Jung P, Mischo CE, Gunaratnam G, Spengler C, Becker SL, Hube B, Jacobs K, Bischoff M. Candida albicans adhesion to central venous catheters: Impact of blood plasma-driven germ tube formation and pathogen-derived adhesins. Virulence. 2020;11:1453–65.
doi: 10.1080/21505594.2020.1836902
Watanabe T, Ogasawara A, Mikami T, Matsumoto T. Hyphal formation of Candida albicans is controlled by electron transfer system. Biochem Biophys Res Commun. 2006;348:206–11.
doi: 10.1016/j.bbrc.2006.07.066
Kurakado S, Takatori K, Sugita T. Minocycline inhibits Candida albicans budded-to-hyphal-form transition and biofilm formation. Jpn J Infect Dis. 2017;70:490–4.
doi: 10.7883/yoken.JJID.2016.369
Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of single- and multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018;16:19–31.
doi: 10.1038/nrmicro.2017.107

Auteurs

Hitoshi Kamauchi (H)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan. kamauchi@josai.ac.jp.

Miho Furukawa (M)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Yuka Kiba (Y)

School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Masashi Kitamura (M)

School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Kanako Usui (K)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Masanori Katakura (M)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Koichi Takao (K)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Yoshiaki Sugita (Y)

Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyaki-dai, Sakado, Saitama, 350-0295, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH